性染色体数目异常与静脉血栓栓塞症的关联
该回顾性队列研究分析了美国MyCode社区健康计划和英国生物银行共642,544名个体的X、Y染色体剂量与静脉血栓栓塞症(VTE)发病率,发现超数性染色体非整倍体成人相比两条性染色体者VTE风险升高,但绝对风险增加较小,作者认为需进一步研究其临床意义。
要点
- 在MyCode队列中,超数性染色体非整倍体者10年随访VTE发生率为每1353人年17例(1.3%/人年),风险比5.4(95%CI 3.4-8.7)。
- 在英国生物银行队列中,超数性染色体非整倍体者10年随访VTE发生率为每3803人年16例(0.42%/人年),风险比4.1(95%CI 2.5-6.7)。
- 两个队列中10年风险差分别为8.8%(95%CI 4.2%-14.0%)和3.7%(95%CI 1.4%-5.9%),均P<.001。
核心结论
- 相比两条性染色体,超数性染色体非整倍体成人VTE风险有小幅但统计学显著的升高。
- 作者指出需进一步研究以理解该关联的临床意义。
研究设计与样本
- 回顾性队列研究,分析642,544名个体的X、Y染色体剂量与VTE发病率。
- 数据来自美国Geisinger MyCode社区健康计划(N=154,519)和英国生物银行(N=488,025),分析限于自认白人者。
- VTE分析纳入108,461名无亲缘关系的MyCode参与者(电子健康记录随访1996年9月至2020年12月)和418,725名无亲缘关系的英国/爱尔兰UK Biobank参与者(基线评估2006年3月至2010年10月,随访至2020年11月)。
主要发现
- MyCode队列中,超数性染色体非整倍体者10年随访发生17例VTE/1353人年(1.3%/人年),46,XX或46,XY者为2060例/816,682人年(0.25%/人年),风险比5.4(95%CI 3.4-8.7),10年风险差8.8%(95%CI 4.2%-14.0%),P<.001。
- UK Biobank队列中,超数性染色体非整倍体者10年随访发生16例VTE/3803人年(0.42%/人年),46,XX或46,XY者为4491例/3,970,467人年(0.11%/人年),风险比4.1(95%CI 2.5-6.7),10年风险差3.7%(95%CI 1.4%-5.9%),P<.001。
临床怎么用
- 原文未据此给出推荐。
局限性
- 分析仅限自认白人者,因其他种族和族裔组样本量不足。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: An increased risk of venous thromboembolism (VTE) has been reported in men with an additional sex chromosome. The association between other sex chromosome aneuploidies and VTE is not well characterized. OBJECTIVE: To determine if sex chromosome aneuploidy is associated with VTE. DESIGN, SETTING, AND PARTICIPANTS: Retrospective cohort study of sex chromosome aneuploidy and VTE, performed by analyzing X- and Y-chromosome dosage and VTE incidence in 642 544 individuals from 2 population-scale biobanks: the US Geisinger MyCode Community Health Initiative (N = 154 519) and the UK Biobank (N = 488 025); analysis was limited to participants self-identified as White because of inadequate sample sizes for other race and ethnicity groups. A total of 108 461 unrelated MyCode participants with electronic health record follow-up ranging from September 1996 to December 2020 and 418 725 unrelated British and Irish UK Biobank participants who attended the baseline assessment between March 2006 and October 2010, with follow-up extending to November 2020, were included in analyses of VTE. EXPOSURES: Sex chromosome aneuploidies. MAIN OUTCOMES AND MEASURES: Individuals with 1 primary inpatient VTE diagnosis, 2 primary outpatient VTE diagnoses, or a self-reported VTE diagnosis were defined as VTE cases. P values were adjusted for multiple comparisons. RESULTS: Identification of sex chromosome aneuploidy was undertaken among 642 544 individuals aged 18 to 90 years. Identification of a diagnosis of VTE was undertaken among 108 461 unrelated MyCode participants (65 565 [60.5%] female; mean age at last visit, 58.0 [SD, 17.6] years; median follow-up, 15.3 [IQR, 9.7] years) and among 418 725 unrelated UK Biobank participants (224 695 [53.7%] female; mean age at baseline interview, 56.9 [SD, 8.0] years; median follow-up, 12.0 [IQR, 1.6] years). Among MyCode participants, during 10 years of follow-up, 17 incident VTE events per 1353 person-years were detected among those with supernumerary sex chromosome aneuploidy (1.3% per person-year) compared with 2060 per 816 682 person-years among those with 46,XX or 46,XY (0.25% per person-year) (hazard ratio, 5.4 [95% CI, 3.4-8.7]; 10-year risk difference, 8.8% [95% CI, 4.2%-14.0%]; P < .001). Among UK Biobank participants, during 10 years of follow-up, 16 incident VTE events per 3803 person-years were detected among those with supernumerary sex chromosome aneuploidy (0.42% per person-year) compared with 4491 per 3 970 467 person-years among those with 46,XX or 46,XY (0.11% per person-year) (hazard ratio, 4.1 [95% CI, 2.5-6.7]; 10-year risk difference, 3.7% [95% CI, 1.4%-5.9%]; P < .001). CONCLUSIONS AND RELEVANCE: Adults with supernumerary sex chromosome aneuploidies compared with 2 sex chromosomes had a small but statistically significant increased risk of VTE. Further research is needed to understand the clinical implications of this association.
引用
- Berry ASF, Finucane BM, Myers SM, et al. Association of Supernumerary Sex Chromosome Aneuploidies With Venous Thromboembolism. JAMA. 2023. PMID: 36648468. doi:10.1001/jama.2022.23897
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。